MELINDA HIGHT: Open Payments
NPI 1275681009 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 28 payments from 13 companies in 2025. Trend: 2023 $196 · 2024 $587 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $133 |
| Sumitomo Pharma America, Inc. | 4 | $86 |
| ABBVIE INC. | 4 | $79 |
| ACCORD HEALTHCARE, INC. | 2 | $47 |
| Calyxo, Inc. | 2 | $41 |
| TOLMAR, INC. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Dendreon Pharmaceuticals LLC | 1 | $32 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $26 |
Products named: XTANDI, BOTOX, GEMTESA, Camcevi, CVAC ASPIRATION SYSTEM, PLUVICTO, PROVENGE, PYLARIFY.
Industry payments across IN — which companies pay providers there.
